High throughput in vivo protease inhibitor selection platform

Publication: ResearchPatent – Annual report year: 2017

View graph of relations

The invention relates to a recombinant microbial cell comprising a selection platform for screening for a protease inhibitor, wherein the platform comprises transgenes encoding a protease having selective peptide bond cleavage activity at a recognition site amino acid sequence; and transgenes encoding polypeptides conferring resistance to microbial growth inhibitors; wherein the polypeptides comprise the recognition site amino acid sequence cleavable by the protease. Protease inhibitors are detected by their ability to inhibit protease specific cleavage and inactivation of the polypeptides whose activity is required for conferring resistance to the microbial growth inhibitors. The invention further relates to recombinant microbial host cell libraries of metagenomic DNA that further comprise the selection platform; and the use of a recombinant microbial cell comprising the selection platform for screening for a protease inhibitor.

Original languageEnglish
IPCC12Q 1/ 37 A I
Patent numberWO2017186854
Date02/11/2017
CountryInternational Bureau of the World Intellectual Property Organization (WIPO)
StatePublished - 2 Nov 2017
Download as:
Download as PDF
Select render style:
APAAuthorCBE/CSEHarvardMLAStandardVancouverShortLong
PDF
Download as HTML
Select render style:
APAAuthorCBE/CSEHarvardMLAStandardVancouverShortLong
HTML
Download as Word
Select render style:
APAAuthorCBE/CSEHarvardMLAStandardVancouverShortLong
Word

ID: 139430211